Parameter | Indications | Contraindications |
Clinical | Age <75 years | Age ≥75 years |
Ex-smoker (>6 months) | Current smoking | |
Clinical picture consistent with emphysema | Surgical constraints (eg, previous thoracic procedure, pleurodesis, chest wall deformity) | |
Dyspnea despite maximal medical therapy and pulmonary rehabilitation | Pulmonary hypertension (PA systolic >45 mmHg, PA mean >35 mmHg) | |
Comorbid illness* | Clinically significant bronchiectasis | |
Clinically significant coronary heart disease | ||
Heart failure with an ejection fraction <45 percent | ||
Uncontrolled hypertension | ||
Obesity¶ | ||
Physiology | FEV1 after bronchodilator <45 percent predicted | FEV1 ≤20 percent predicted with either DLCO ≤20 percent predicted or homogeneous emphysema |
Hyperinflation (TLC >100 percent predicted, RV >150 percent) | PaO2 ≤45 mmHg on room air | |
Post rehabilitation 6-minute walk distance >140 meters | PaCO2 ≥60 mmHg | |
Low post rehabilitation maximal achieved cycle ergometry wattsΔ | ||
Imaging | Chest radiograph - hyperinflation | |
HRCT confirming severe emphysema, ideally with upper lobe predominance | Homogeneous emphysema with FEV1 ≤20 percent predicted | |
Significant pleural or interstitial changes on HRCT | ||
Nonupper lobe predominant emphysema and high post rehabilitation maximal achieved cycle ergometry watts◊ |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟